Impact BioMedical Inc. (IBO)
NYSEAMERICAN: IBO · Real-Time Price · USD
0.632001
-0.0110 (-1.71%)
May 6, 2026, 11:59 AM EDT - Market open
Impact BioMedical Market Cap
Impact BioMedical has a market cap or net worth of $68.14 million as of May 6, 2026. Its market cap has increased by 1,243.45% in one year.
Market Cap
68.14M
Enterprise Value
68.89M
1-Year Change
1,243.45%
Ranking
Category
Stock Price
$0.63
Market Cap Chart
Since the IPO on September 16, 2024, Impact BioMedical's market cap has increased from $34.49M to $68.14M, an increase of 97.56%. That is a compound annual growth rate of 51.73%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 5, 2026 | 69.33M | 31.22% |
| Dec 31, 2025 | 52.83M | 216.73% |
| Dec 31, 2024 | 16.68M | -51.64% |
| Sep 16, 2024 | 34.49M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Q32 Bio | 73.73M |
| Seres Therapeutics | 73.72M |
| Pliant Therapeutics | 73.68M |
| Sangamo Therapeutics | 73.58M |
| TScan Therapeutics | 73.32M |
| Actuate Therapeutics | 69.95M |
| OS Therapies | 69.78M |
| MediciNova | 68.91M |